Specialty
RSSArticles
-
Teletriage Applications Help EDs Improve Efficiency, Respond to COVID-19 Pandemic
As the demand for virtual care has accelerated, teletriage has melded well with other telemedicine innovations that may permanently change many of the ways in which emergency care is delivered. Some early adopters explain what pushed them out of the gate early, how teletriage has helped them manage the challenges posed by COVID-19, and how they see the approach evolving.
-
CDC Revises COVID-19 Quarantine Recommendations
Now, quarantine can end after 10 days without a COVID-19 test if the person has reported no symptoms, or after seven days with a negative test if the person has reported no symptoms.
-
The Work of Vaccinating Frontline Healthcare Workers Against COVID-19 Begins
Hospitals are scrambling to ensure a smooth and effective process for vaccinating frontline healthcare workers against COVID-19. Leaders need to quickly equip their personnel with enough information to persuade them that the vaccine is safe and effective.
-
Casirivimab + Imdevimab Injection
Casirivimab/imdevimab should be used to treat mild to moderate COVID-19 in adults and patients ≥ 12 years of age weighing at least 40 kg who have tested positive for SARS-CoV-2.
-
Multiple Sclerosis and Vascular Disease
Researchers evaluated the presence and pathological significance of extracranial systemic and cerebral small vessel disease in patients with multiple sclerosis (MS) compared to healthy controls. MS patients exhibited less systemic vascular disease and more small vessel disease in the brain vs. controls.
-
Antibiotics for Traveler’s Diarrhea
International travel carries a risk of colonization by antimicrobial-resistant intestinal flora. Using quinolone, but not a macrolide, during travel further increases the risk of acquisition of extended-spectrum, beta-lactamase-producing Enterobacteriaceae.
-
The Effect of Age on Cholesterol-Lowering Therapy
Investigators analyzed data on the effect of age on cardiovascular (CV) outcomes and LDL cholesterol-lowering by alirocumab vs. placebo in recent acute coronary syndrome patients. They found alirocumab can lower the rate of CV events regardless of age — and produce more absolute benefit with age.
-
Healthcare Personnel COVID-19 Hospitalizations and Vaccine Prioritization
During the period of study, 5.9% of individuals hospitalized for COVID-19-related reasons were healthcare providers (HCP), with approximately one-third involving HCP who were not expected to directly contact patients.
-
Managing Appendicitis Medically
A multicenter, randomized trial showed that 10 days of antibiotics results in comparable outcomes as surgery. Three in 10 patients treated with antibiotics required surgery within 90 days.
-
Even Moderate COVID-19 Cases Can Cause Serious Neurological Problems
Strokes, seizures, and movement disorders just a few complications observed.